Showing results (471-480 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.Neuro-Oncology|April 8, 2023
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patientsMyrsini Ioakeim-Ioannidou, Andrzej Niemierko, Daniel W Kim, et al.Neuro-Oncology|June 20, 2008
Genetic variation in insulin-like growth factors and brain tumor riskStefan Lönn, Nathaniel Rothman, William R Shapiro, et al.Neuro-Oncology|May 26, 2006
Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft modelRyuta Saito, Michal T Krauze, Charles O Noble, et al.Neuro-Oncology|May 26, 2006
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiformeAbdeljabar El Andaloussi, Maciej S LesniakNeuro-Oncology|May 26, 2006
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in gliomaChristine Billecke, Susan Finniss, Laura Tahash, et al.Neuro-Oncology|September 2, 2008
High-dose methotrexate for elderly patients with primary CNS lymphomaJay-Jiguang Zhu, Elizabeth R Gerstner, David A Engler, et al.Neuro-Oncology|October 17, 2008
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastomaAnnalisa Pezzolo, Elena Rossi, Stefania Gimelli, et al.Neuro-Oncology|October 28, 2008
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsGaspar J Kitange, Brett L Carlson, Mark A Schroeder, et al.Neuro-Oncology|November 13, 2007
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaGraziella Filippini, Chiara Falcone, Amerigo Boiardi, et al.Pageof 315